6-008.7:
Administration of medication: Administration of medication, list 8: Blinatumomab, parenteral
- 6-008.70 9 µg to under 18 µg
- 6-008.71 18 µg to under 27 µg
- 6-008.72 27 µg to under 36 µg
- 6-008.73 36 µg to under 45 µg
- 6-008.74 45 µg to under 54 µg
- 6-008.75 54 µg to under 63 µg
- 6-008.76 63 µg to under 72 µg
- 6-008.77 72 µg to under 100 µg
- 6-008.78 100 µg to under 130 µg
- 6-008.79 130 µg to under 160 µg
- 6-008.7a 160 µg to under 220 µg
- 6-008.7b 220 µg to under 280 µg
- 6-008.7c 280 µg to under 400 µg
- 6-008.7d 400 µg to under 520 µg
- 6-008.7e 520 µg to under 640 µg
- 6-008.7f 640 µg to under 760 µg
- 6-008.7g 760 µg to under 1,000 µg
- 6-008.7h 1,000 µg to under 1,480 µg
- 6-008.7j 1,480 µg to under 1,960 µg
- 6-008.7k 1,960 µg to under 2,920 µg
- 6-008.7m 2,920 µg to under 3,880 µg
- 6-008.7n 3,880 µg to under 4,840 µg
- 6-008.7p 4,840 µg to under 5,800 µg
- 6-008.7q 5,800 µg or more
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).